Jiangfang Tian Zhen Lin Yueyun Chen Yang Fu Zhenyu Ding
10.3389/fonc.2022.1006634
Front Oncol
2022 Oct 27;12:1006634.
met exon 14 skipping mutation (metex14) nsclc case report major pathological response neoadjuvant therapy savolitinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/36387081/
Case Reports
PMC9646987
36387081
Dramatic response to neoadjuvant savolitinib in marginally resectable lung adenocarcinoma with MET exon 14 skipping mutation: A case report and literature review
2022